FINHUB Insights

PODD · Q1 FY26 · Mar 31, 2026

Insulet Q1 FY26: where the revenue came from and where it went

Insulet Q1 FY26: revenue $0.8B (+34% year over year). Net profit $0.1B. Largest cohort U.S.Omnipod $0.5B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 31, 2026
Reported
May 6, 2026 10-Q
Sankey diagram of Insulet's income statement for Q1 FY26: revenue of $0.8 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.8B +34% year over year
Gross profit$0.5B 69% margin
Operating profit$0.1B 16% margin
Net profit$0.1B 12% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 0.8 100% +34%
U.S.Omnipod 0.5 62% +28%
International Omnipod 0.2 25% +59%
Cost of revenue−0.225%
Gross profit0.569% margin−2pp
Research & development−0.112%+1pp
SG&A−0.342%−4pp
Operating profit0.116% margin+0pp
Net profit0.112%+6pp
Filing on EDGAR More quarters of PODD

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters